financetom
Business
financetom
/
Business
/
Why Lumen Technologies Shares Are Moving Higher Tuesday
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Why Lumen Technologies Shares Are Moving Higher Tuesday
Aug 6, 2024 11:23 AM

Lumen Technologies, Inc. ( LUMN ) shares are moving higher Tuesday after the company announced it secured $5 billion in new business.

What Happened: The company stated that the $5 billion in new business was mostly driven by companies seeking to secure fiber capacity swiftly.

Fiber capacity is a resource that has become more valuable due to artificial intelligence. In order to meet this demand, the company said it will more than double its intercity network miles over the next five years and it secured an agreement with Corning be its preferred partner for its next-generation fiber-dense cable.

Lumen has already taken steps to meet this demand through its recent deal with Microsoft Corporation ( MSFT ) . The company said it is working to secure an additional $7 billion in protentional sales opportunities.

“The AI economy is changing business operations, and companies are recognizing they need powerful network infrastructure to manage the unprecedented data flows today and the demand in the future,” said Kate Johnson, president and CEO, Lumen Technologies ( LUMN ).

“Our partners are turning to us because of our AI-ready infrastructure and expansive network. This is just the beginning of a significant opportunity for Lumen, one that will lead to one of the largest expansions of the internet ever.”

Related Link: GlobalFoundries Exceeds Q2 Projections, Navigates High Inventory Levels In Chip Market

LUMN Price Action: At the time of writing, Lumen shares are trading 88.4% higher at $4.88, according to data from Benzinga Pro.

Image: 7997618 from Pixabay.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Zai Lab Licenses MediLink Therapeutics' Antibody-Drug Conjugate Platform
Zai Lab Licenses MediLink Therapeutics' Antibody-Drug Conjugate Platform
Jan 10, 2025
04:39 AM EST, 01/10/2025 (MT Newswires) -- Zai Lab ( ZLAB ) said late Thursday it has struck a licensing agreement to use MediLink Therapeutics' Tmalin antibody-drug conjugate platform for the development of its ZL-6201 investigational drug. Financial terms were not disclosed. Zai Lab ( ZLAB ) said the partnership will expand its oncology pipeline with another drug targeting multiple...
Innate Pharma to Focus on NK Cell Therapies, ADC Development to Accelerate Growth
Innate Pharma to Focus on NK Cell Therapies, ADC Development to Accelerate Growth
Jan 10, 2025
04:39 AM EST, 01/10/2025 (MT Newswires) -- Innate Pharma ( IPHA ) said Friday it is prioritizing its antibody-based NK Cell Engager platform to target hematologic cancers, solid tumors, and autoimmune diseases. The company said it is currently testing its NK Cell Engager, IPH6501, in a phase 1/2 trial for non-Hodgkin's lymphoma. Additionally, Innate said it is advancing its Antibody-Drug...
India names Diageo, Sequoia Capital in case alleging suspicious payments
India names Diageo, Sequoia Capital in case alleging suspicious payments
Jan 10, 2025
* Diageo ( DEO ), Sequoia Capital face influence-peddling investigation * Diageo ( DEO ) made payment to lift ban on duty-free items -agency * Sequoia made payments for investment approval -agency By Arpan Chaturvedi NEW DELHI, Jan 10 (Reuters) - India's federal investigating agency has accused liquor giant Diageo ( DEO ) and Sequoia Capital of making suspicious payments...
Amylyx Pharmaceuticals Launches Stock Offering
Amylyx Pharmaceuticals Launches Stock Offering
Jan 10, 2025
04:31 AM EST, 01/10/2025 (MT Newswires) -- Amylyx Pharmaceuticals ( AMLX ) said late Thursday it has commenced an underwritten public offering of common shares. Amylyx plans to give the underwriter a 30-day option to buy up to an additional 15% of the shares offered. The company said the proceeds will be used to support commercialization, pipeline programs, working capital...
Copyright 2023-2026 - www.financetom.com All Rights Reserved